In Taiwan, second doses of the Pfizer-BioNTech COVID-19 vaccine are being temporarily suspended for children between the ages of 12 and 17 due to concerns over the risk of myocarditis. Chen Shih-chung, the head of Taiwan’s Central Epidemic Command Center, announced the news on Nov. 10. A final decision, he said, is expected in two weeks. A new report from Taiwan’s Central News Agency detailed the ongoing situation. So far, the website reported, 1.1 million people between the ages of 12 and 17 have received their first dose of the Pfizer-BioNTech vaccine in Taiwan.